Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Improved prognosis of postoperative hepatocellular carcinoma patients when treated with functional foods: a prospective cohort study.

Matsui Y, Uhara J, Satoi S, Kaibori M, Yamada H, Kitade H, Imamura A, Takai S, Kawaguchi Y, Kwon AH, Kamiyama Y.

J Hepatol. 2002 Jul;37(1):78-86.

PMID:
12076865
2.

Longterm prognosis after hepatic resection for small hepatocellular carcinoma.

Shimozawa N, Hanazaki K.

J Am Coll Surg. 2004 Mar;198(3):356-65.

PMID:
14992736
3.

Is liver resection justified in advanced hepatocellular carcinoma? Results of an observational study in 464 patients.

Ruzzenente A, Capra F, Pachera S, Iacono C, Piccirillo G, Lunardi M, Pistoso S, Valdegamberi A, D'Onofrio M, Guglielmi A.

J Gastrointest Surg. 2009 Jul;13(7):1313-20. doi: 10.1007/s11605-009-0903-x. Epub 2009 May 6.

PMID:
19418103
4.

Prognosis and results after resection of very large (>or=10 cm) hepatocellular carcinoma.

Shah SA, Wei AC, Cleary SP, Yang I, McGilvray ID, Gallinger S, Grant DR, Greig PD.

J Gastrointest Surg. 2007 May;11(5):589-95.

PMID:
17393258
5.

Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.

Shah SA, Cleary SP, Wei AC, Yang I, Taylor BR, Hemming AW, Langer B, Grant DR, Greig PD, Gallinger S.

Surgery. 2007 Mar;141(3):330-9. Epub 2006 Nov 1.

PMID:
17349844
6.

Hepatitis B genotypes correlate with tumor recurrence after curative resection of hepatocellular carcinoma.

Chen JD, Liu CJ, Lee PH, Chen PJ, Lai MY, Kao JH, Chen DS.

Clin Gastroenterol Hepatol. 2004 Jan;2(1):64-71.

PMID:
15017634
7.

Prognostic improvement of patients with advanced liver cancer after active hexose correlated compound (AHCC) treatment.

Cowawintaweewat S, Manoromana S, Sriplung H, Khuhaprema T, Tongtawe P, Tapchaisri P, Chaicumpa W.

Asian Pac J Allergy Immunol. 2006 Mar;24(1):33-45.

8.

Accompanying liver cirrhosis as a risk factor for recurrence after resection of solitary hepatocellular carcinoma.

Takada Y, Otsuka M, Todoroki T, Fukao K.

Hepatogastroenterology. 2003 Nov-Dec;50(54):1991-5.

PMID:
14696450
9.

Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy.

Huang J, Li BK, Chen GH, Li JQ, Zhang YQ, Li GH, Yuan YF.

J Gastrointest Surg. 2009 Sep;13(9):1627-35. doi: 10.1007/s11605-009-0933-4. Epub 2009 Jun 9.

PMID:
19506976
10.

Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection.

Yang LY, Fang F, Ou DP, Wu W, Zeng ZJ, Wu F.

Ann Surg. 2009 Jan;249(1):118-23. doi: 10.1097/SLA.0b013e3181904988.

PMID:
19106686
11.

High serum des-gamma-carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma.

Kobayashi M, Ikeda K, Kawamura Y, Yatsuji H, Hosaka T, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Saitoh S, Arase Y, Kumada H.

Cancer. 2009 Feb 1;115(3):571-80. doi: 10.1002/cncr.24031.

12.

Feasibility of salvage liver transplantation for patients with recurrent hepatocellular carcinoma.

Hu RH, Ho MC, Wu YM, Yu SC, Lee PH.

Clin Transplant. 2005 Apr;19(2):175-80.

PMID:
15740552
13.

Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.

Ueno S, Sakoda M, Kubo F, Hiwatashi K, Tateno T, Baba Y, Hasegawa S, Tsubouchi H; Kagoshima Liver Cancer Study Group.

J Hepatobiliary Pancreat Surg. 2009;16(3):359-66. doi: 10.1007/s00534-009-0069-7. Epub 2009 Mar 20.

PMID:
19300896
14.

Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma.

Ng KK, Poon RT, Lo CM, Yuen J, Tso WK, Fan ST.

J Gastrointest Surg. 2008 Jan;12(1):183-91. Epub 2007 Sep 15.

PMID:
17874276
15.

Predictors and patterns of recurrence after resection of hepatocellular carcinoma.

Cha C, Fong Y, Jarnagin WR, Blumgart LH, DeMatteo RP.

J Am Coll Surg. 2003 Nov;197(5):753-8.

PMID:
14585409
16.

Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study.

Regimbeau JM, Abdalla EK, Vauthey JN, Lauwers GY, Durand F, Nagorney DM, Ikai I, Yamaoka Y, Belghiti J.

J Surg Oncol. 2004 Jan;85(1):36-41.

PMID:
14696085
17.

Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma.

Okuwaki Y, Nakazawa T, Kokubu S, Hidaka H, Tanaka Y, Takada J, Watanabe M, Shibuya A, Minamino T, Saigenji K.

Am J Gastroenterol. 2009 Nov;104(11):2747-53. doi: 10.1038/ajg.2009.414. Epub 2009 Jul 14.

PMID:
19603009
18.

Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma.

Katz SC, Shia J, Liau KH, Gonen M, Ruo L, Jarnagin WR, Fong Y, D'Angelica MI, Blumgart LH, Dematteo RP.

Ann Surg. 2009 Apr;249(4):617-23. doi: 10.1097/SLA.0b013e31819ed22f.

PMID:
19300227
19.

Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy.

Takahashi S, Kudo M, Chung H, Inoue T, Ishikawa E, Kitai S, Tatsumi C, Ueda T, Minami Y, Ueshima K, Haji S.

Oncology. 2007;72 Suppl 1:98-103. Epub 2007 Dec 13.

PMID:
18087189
20.

Prognosis of early hepatocellular carcinoma after hepatic resection.

Maeda T, Shimada M, Harimoto N, Tsujita E, Aishima S, Tanaka S, Shirabe K, Maehara Y.

Hepatogastroenterology. 2008 Jul-Aug;55(85):1428-32.

PMID:
18795705

Supplemental Content

Support Center